title: Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: a case report.
abstract: Gastric cancer is one of the most common cancers worldwilde. The five-year survival for stage IV gastric cancer is around 5-10% in Western countries. Advanced gastric cancer is sensitive to numerous agents, but there is no generally accepted standard regimen. Here we report on a case of advanced gastric cancer occurring in a 72-year-old man who underwent treatment with capecitabine plus oxaliplatin, achieving a complete response.
authors.affiliation: Dipartimento di Oncologia,Divisione Oncologia Medica, ARNAS Ospedale Civico, Palermo. rosariomazzola@hotmail.it
authors.forename: Rosario
authors.initials: R
authors.lastname: Mazzola
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Alù
authors.forename: Vita
authors.initials: V
authors.lastname: Leonardi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Procopio
authors.forename: Biagio
authors.initials: B
authors.lastname: Agostara
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil